Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: management of medication related osteonecrosis of the jaw.
- Who it may be relevant to
- Registry conditions: Osteomyelitis of Jaw. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Management of Medication Related Osteonecrosis of the Jaws Using Piezosurgery With Simultaneous Double Periosteal Flap Closure
Overview
20 patients with MRONJ underwent surgical debridement using piezosurgery then closure using double periosteal flap
Detailed description
20 patients with MRONJ underwent surgical debridement, crestal incision and oblique releasing incision were performed to expose the area of osteomyelitis, then squesterum was removed using piezosurgery. After complete debridement, the periosteal layer was dissected from mucoperiosteal buccal flap and based superiorly, then turn upward to be sutured to the lingual flap followed by suturing of buccal flap to achieve double layers closure
Interventions
- Device management of medication related osteonecrosis of the jaw
after buccal flap reflection, the bone osteonecrosis was debrided using piezosurgery. the buccal mucoperiosteal flap was dissected to two layers first, the periosteal layer was based superiorly and the mucosal flap to achieve double layers closure.
Primary outcome measures
- evaluation of pain [Time frame: one month]
- wound healing [Time frame: one -3 months]
Eligibility criteria
Inclusion criteria
- patients with MRONJ
Exclusion criteria
- Patients had a history of radiotherapy
- Patients need only conservative treatment
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Faculty of Dentistry, Tanta University — Tanta
Identifiers
NCT: NCT07177378 · 1981